Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
This intro explains what a high index level may indicate in terms of trend strength, momentum, and potential market overheating.
25,925 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Investors are watching a handful of tech names retreat despite strong long term potential. This guide explains how be...
Investors are weighing how legal rulings against Meta could reshape risk and earnings. This guide breaks down what ha...
Insider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
Rivian shares have faced a meaningful pullback, leaving many investors wondering if the rivian stock dip? creates a b...
A major headline sent Goldman Sachs stock popping, tied to reports it could lead SpaceX's mega-IPO. This article brea...
A large institutional bet on Futu stock sparked headlines as shares fell nearly a quarter. This article breaks down w...
A major fund recently disclosed a large move in Globalstar as the stock surged. This article explains what happened, ...
As Micron prepares to report on June 24, investors buzz about a potential stock surge. This guide breaks down catalys...
Investors are debating whether Palantir stock can still deliver. This guide breaks down the growth story, the risks, ...
Riot Platforms lit up the market in May with a dramatic 57% gain, riding AI computing demand and energy strategy news...
When a legendary investor shifts big positions, traders sit up. This piece breaks down what it could mean that billio...